Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Xact Bear XACTBEAR Jan 23, 2020 43.27 +1.26   
 Xact Bear 2 XACTBEAR2 Jan 23, 2020 32.08 +1.63   
 Xact Bull XACTBULL Jan 23, 2020 460.10 -1.17   
 Xact Bull 2 XACTBULL2 Jan 23, 2020 925.90 -1.55   
 XACT Högutdelande XACTHDIV Jan 23, 2020 131.94 -0.90   
 Xact OMXS30 XACTOMXS30 Jan 23, 2020 225.35 -0.81   
 XANO Industri B XANOB Jan 23, 2020 111.00 -0.89   
 Xavitech B XAVIB Jan 23, 2020 1.18 +1.72   
 Xbrane Biopharma XBRANE Jan 23, 2020 41.60 +4.00   
 Xintela XINT Jan 23, 2020 4.39 -1.13   
 XMReality XMR Jan 23, 2020 3.12 -2.50   
 Xspray Pharma XSPRAY Jan 23, 2020 80.40 +0.50   
 Xvivo Perfusion XVIVO Jan 23, 2020 186.60 -0.64   
 XXL XXLO Jan 23, 2020 12.40 -5.05   
 Yara International YARO Jan 23, 2020 340.10 -2.49   
 Zaplox ZAPLOX Jan 23, 2020 2.00 -18.37   
 Zenergy B ZENZIPB Jan 23, 2020 0.45 +0.45   
 Zenicor ZENI Jan 23, 2020 13.80 0.00   
 ZetaDisplay ZETA Jan 23, 2020 22.70 +2.25   
 Ziccum ZICC Jan 23, 2020 14.00 -0.71   
 ZignSec ZIGN Jan 23, 2020 8.91 0.00   
 Zinzino B ZZB Jan 23, 2020 31.90 +2.24   
 Zoomability ZOOM Jan 23, 2020 4.72 -4.07   
 Zordix B ZORDIXB Jan 23, 2020 9.80 -0.20   
 Zutec ZUTEC Jan 23, 2020 1.05 -4.09   
 ÅF Pöyry B AFB Jan 23, 2020 245.00 -1.53   
 Öresund ORES Jan 23, 2020 131.20 +1.71   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK